Oragenics Announces Recent Capital Raise and Warrant Exercises Totaling $21.9 Million and the Redemption of Its Series C Preferred Stock
Amount Raised
$21 Million
Round Type
Series C
SarasotaBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) announced it has raised approximately $20 million from the sale of common stock through a sales agreement with A.G.P./Alliance Global Partners for an “at-the-market” facility. In addition, the Company also received approximately $1.9 million from the exercise of common stock warrants. In turn, Oragenics has given a notice for the redemption of all outstanding shares of the Company’s Series C, Non-Convertible, Preferred Stock (the “Series C Preferred Stock”) to the holder of the Series C Preferred Stock.
Quick answer
Oragenics raised $21 Million in a Series C round, dated February 12, 2021. Oragenics is based in Sarasota, Florida, United States.
- How much did Oragenics raise?
- Oragenics raised $21 Million in a Series C round on February 12, 2021.
- What does Oragenics do?
- Oragenics, Inc. is a biopharmaceutical company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders.
- Where is Oragenics based and how big is it?
- Oragenics is based in Sarasota, Florida, United States. Fundz records about 18 employees.
- Who are the decision-makers at Oragenics?
- Fundz holds 1 contact at Oragenics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Oragenics that raised within 45 days of this round, from Fundz verified event records.
- Day One Biopharmaceuticals raised $130M (Series B) on February 10, 2021.
- ISOThrive raised $5.2M on February 5, 2021.
- Parabilis Medicines raised $23M on January 5, 2021.
- Azora Therapeutics, Inc. (DE) raised $291K on March 26, 2021.
- Camp4 Therapeutics Corp raised $15M on March 19, 2021.
- OnKure Therapeutics raised $29M on March 5, 2021.
Who to call at Oragenics, and when
A new round usually means Oragenics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Oragenics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Oragenics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Oragenics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Oragenics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Oragenics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.